首页/行业动态/论文详情

口服超细颗粒黄芪通过上调补体调节剂C4bp和免疫球蛋白反应增强断奶黑湘东山羊外周免疫

Oral administration of ultrafine-grained Astragalus membranaceus enhances peripheral immunity in weaned black Xiangdong goats by upregulating the complement regulator C4bp and immunoglobulin responses.

科研进展PubMed 论文(TCM 食品)机译
  • 期刊Molecular biology reports(Mol Biol Rep)
  • 发表时间2026-10-08
  • 作者Liao J, Sun J, Gebeyew K, Khan NA, Liu Y
  • 卷期页码V53(1)
  • DOI10.1007/s11033-026-12883-8
  • PMID42848100

摘要机译

黄芪是中药中广泛使用的免疫调节草药;然而,其超细颗粒粉末(UGAM)对年轻反刍动物外周免疫系统的影响在很大程度上仍未被探索。36只断奶黑湘东山羊(产后42天;5.34±1.342公斤)被随机分配到对照组(n=16;仅基础日粮)和UGAM组(n=20;

出生后第43-78天,包括8天适应期的对照加10 g/d UGAM)。在出生后第78天,分析血液样本中的补体蛋白(C1q、C1r、C1s、C3、C4、C4bp和因子H)、免疫球蛋白(IgA、IgG和IgM)和炎症细胞因子(IL-1α、IL-1β、IL-6、IL-10、TNF-α和IFN-γ)以及外周血细胞谱。

使用RT-qPCR在随机选择的动物子集(对照n=11;UGAM n=16)中测量肝脏补体基因表达。UGAM显著增加血清C4bp浓度和血清和肝脏C4bp mRNA表达(p<0.001),增加外周IgM浓度(p=0.032),而IgA、IgG和所有测量的炎症细胞因子(IL-1α、IL-1β、IL-6、IL-10、TNF-α和IFN-γ)保持不变(p>0.05)。

在多参数分析中,UGAM治疗与C4bp呈独立正相关(部分r=0.74,p<0.001),补体系统的整体相关结构与免疫球蛋白呈正相关(Mantel r=0.36,p=0.001)。

口服UGAM可增加断奶山羊循环C4bp、IgM和肝脏C4bp,这与稳态补体调节和可能的断奶后免疫支持的参与一致。然而,补体活性、浆细胞反应、信号传导和安全性没有测量;机制仍然是假设的,需要验证。

展开英文摘要原文

Astragalus membranaceus is a widely used immunomodulatory herb in traditional Chinese medicine; however, the effects of its ultrafine-grained powder (UGAM) on the peripheral immune system of young ruminants remain largely unexplored. Thirty-six weaned black Xiangdong goats (postnatal day 42; 5.34 ± 1.342 kg) were randomly allocated to a control group (n = 16; basal diet only) and a UGAM group (n = 20; control plus 10 g/d UGAM) from postnatal days 43-78, including 8 days adaption period. On postnatal day 78, blood samples were analyzed for complement proteins (C1q, C1r, C1s, C3, C4, C4bp, and Factor H), immunoglobulins (IgA, IgG, and IgM), and inflammatory cytokines (IL-1α, IL-1β, IL-6, IL-10, TNF-α, and IFN-γ), along with peripheral blood cell profiles. Hepatic complement gene expression was measured in a randomly selected subset of animals (Control n = 11; UGAM n = 16) using RT-qPCR. UGAM significantly increased serum C4bp concentrations and serum and hepatic C4bp mRNA expression (p < 0.001) and increased peripheral IgM concentrations (p = 0.032), whereas IgA, IgG, and all measured inflammatory cytokines (IL-1α, IL-1β, IL-6, IL-10, TNF-α, and IFN-γ) remained unchanged (p > 0.05). In the multi-parameter analysis, UGAM treatment was independently and positively associated with C4bp (partial r = 0.74, p < 0.001), and the overall correlation structure of the complement system was positively associated with that of the immunoglobulins (Mantel r = 0.36, p = 0.001). Oral administration of UGAM increased circulating C4bp and IgM and hepatic C4bp in weaned goats, consistent with engagement of homeostatic complement regulatary and possible post-weaning immune support. However, complement activity, plasma-cell responses, signaling, and safety were not measured; mechanisms remain hypothetical and require validation.

相关物质

PubMed 原文 ↗DOI 入口 ↗

本页由系统自动抓取 PubMed 元数据生成;标题与摘要版权归原作者与期刊所有;机译内容仅供参考,请以英文原文为准;收录不代表本站观点,亦不作为用药或医疗建议。